This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2001;3(3):3.

doi: 10.1208/ps0303_commentary2.

UGT1A1 polymorphism predicts irinotecan toxicity: evolving proof

S Mani¹

Affiliations

PMID: 11783425
PMCID: PMC2751010
DOI: 10.1208/ps0303_commentary2

UGT1A1 polymorphism predicts irinotecan toxicity: evolving proof

S Mani. AAPS PharmSci. 2001.

. 2001;3(3):3.

doi: 10.1208/ps0303_commentary2.

Author

S Mani¹

Affiliation

¹ Medicine/Oncology, Weiler/AECOM Room 2S-63 1825 Eastchester Road Bronx, NY 10461, USA. smani@montefiore.org

PMID: 11783425
PMCID: PMC2751010
DOI: 10.1208/ps0303_commentary2

No abstract available

PubMed Disclaimer

Similar articles

Indispensability of UGT1A1*6 genotyping in Japanese cancer patients treated with irinotecan.
Takano M, Kato M, Yoshikawa T, Goto T, Furuya K, Kikuchi Y. Takano M, et al. Int J Clin Oncol. 2010 Apr;15(2):224-5. doi: 10.1007/s10147-010-0024-2. Epub 2010 Feb 24. Int J Clin Oncol. 2010. PMID: 20179984 No abstract available.
UGT1AI*6 and UGT1A1*27 for individualized irinotecan chemotherapy.
Ando Y, Fujita K, Sasaki Y, Hasegawa Y. Ando Y, et al. Curr Opin Mol Ther. 2007 Jun;9(3):258-62. Curr Opin Mol Ther. 2007. PMID: 17608024 Review.
Severe irinotecan-induced toxicities in a patient with uridine diphosphate glucuronosyltransferase 1A1 polymorphism.
Mehra R, Murren J, Chung G, Smith B, Psyrri A. Mehra R, et al. Clin Colorectal Cancer. 2005 May;5(1):61-4. doi: 10.3816/ccc.2005.n.018. Clin Colorectal Cancer. 2005. PMID: 15929808
Irinotecan pharmacogenomics.
Marsh S, Hoskins JM. Marsh S, et al. Pharmacogenomics. 2010 Jul;11(7):1003-10. doi: 10.2217/pgs.10.95. Pharmacogenomics. 2010. PMID: 20602618 Free PMC article. Review.
Insights, challenges, and future directions in irinogenetics.
Kim TW, Innocenti F. Kim TW, et al. Ther Drug Monit. 2007 Jun;29(3):265-70. doi: 10.1097/FTD.0b013e318068623b. Ther Drug Monit. 2007. PMID: 17529881 Review.

See all similar articles

Cited by

Role of pharmacogenomics in drug discovery and development.
Surendiran A, Pradhan SC, Adithan C. Surendiran A, et al. Indian J Pharmacol. 2008 Aug;40(4):137-43. doi: 10.4103/0253-7613.43158. Indian J Pharmacol. 2008. PMID: 20040945 Free PMC article.
Application of Twitter and web news mining in infectious disease surveillance systems and prospects for public health.
Jahanbin K, Rahmanian F, Rahmanian V, Jahromi AS. Jahanbin K, et al. GMS Hyg Infect Control. 2019 Dec 2;14:Doc19. doi: 10.3205/dgkh000334. eCollection 2019. GMS Hyg Infect Control. 2019. PMID: 32047718 Free PMC article.
Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.
Ni W, Ji J, Dai Z, Papp A, Johnson AJ, Ahn S, Farley KL, Lin TS, Dalton JT, Li X, Jarjoura D, Byrd JC, Sadee W, Grever MR, Phelps MA. Ni W, et al. PLoS One. 2010 Nov 1;5(11):e13792. doi: 10.1371/journal.pone.0013792. PLoS One. 2010. PMID: 21072184 Free PMC article. Clinical Trial.

References

1. Innocenti F, Iyer L, Ratain MJ. Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan. Drug Metab Dispos. 2001;29:596–600. - PubMed
1. Kehrer DF, Sparreboom A, Verweij J, Bruijn P, Nierop CA, Schraaf J, Ruijgrok EJ, Jonge MJ. Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients. Clin Cancer Res. 2001;7:1136–41. - PubMed
1. Ostrow JD, Tiribelli C. Variation in UGT 1A1 activity in Gilberts syndrome. J Hepatol. 2001;34:636–94. doi: 10.1016/S0168-8278(00)00071-4. - DOI - PubMed
1. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000;16:297–306. doi: 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z. - DOI - PubMed
1. Iyer L, Hall D, Das S, Mortell MA, Ramirez J, Kim S, Rienzo A, Ratain MJ. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT 1A1 promoter polymorphism. Clin Pharmacol Ther. 1999;65:576–82. doi: 10.1016/S0009-9236(99)70078-0. - DOI - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central